3,511 results found

Matt Maurer was quoted in "Growing like weed" on the legalization of cannabis and some of​ the difficulties that ​accompany these ​changes. The article was published on May 17, 2017 by Listed Magazine.

Chair of the Cannabis Law Group, Matt Maurer, was quoted in "Tourism business opportunities await as Ontario mulls cannabis in hotels, lounges, RVs" in Marijuana Business Daily on February 8, 2018. He discusses the potential for cannabis tourism in Ontario.

Shares of CannTrust Holdings Inc. dropped 22 per cent on Wednesday, a day after The Globe and Mail reported both CannTrust's chairman

On March 22, 2023, the Minister of Health announced the first-ever National Strategy for Drugs for Rare Diseases

On February 29, 2024, the Minister of Health announced the introduction of Bill C-64, An Act respecting pharmacare (Pharmacare Act), which "proposes the foundational principles...

On Oct. 25, 2018, international cannabis eCommerce company Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) closed its previously announced bought deal short form prospectus...

On March 13, 2019, Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) announced that it had completed the previously announced acquisition of 49%

New Court Proceedings - October 2018

Catherine Bate & Kelly Harris have prepared a piece for Global Advertising Lawyers Alliance (GALA) on "New Nutrition Criteria for Food Advertising to Children."

As previously reported, in December 2017, Apotex was awarded over $11M in damages and pre-judgment interest for losses flowing from delays ...

On April 1, 2014, a Standing Committee of the Ontario Government on Social Policy published its report on Diluted Chemotherapy Drugs.

Chain restaurants will now have less than a year to post caloric information and bring menus, flyers, advertisements, websites, and premises into compliance.

The government of Ontario has signaled its intention to formally regulate preferred pharmacy networks ("PPNs") in employer-sponsored drug benefit plans.

The Regulations published are in substantially the same form as previously presented in the Notice of May 3, 2015.

While originally proposed to come into force on January 1, 2019, sweeping amendments to the Patented Medicines Regulations governing pricing criteria were still not released as of June 30

CADTH has provided an online questionnaire for stakeholders to provide feedback; the online consultation period will run through to February 25, 2022.

This video is the third in a series of four which will explain the legal framework of the health care system, and regulation of drugs and drug pricing, in Canada at the federal and provincial...

With the Royal Assent of Québec Bill 28, the Minister of Health and Social Services (the Minister) can now enter into product listing agreements (PLAs) with pharmaceutical drug manufacturers.